Welcome to LookChem.com Sign In|Join Free

CAS

  • or

83070-15-9

Post Buying Request

83070-15-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

83070-15-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 83070-15-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,3,0,7 and 0 respectively; the second part has 2 digits, 1 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 83070-15:
(7*8)+(6*3)+(5*0)+(4*7)+(3*0)+(2*1)+(1*5)=109
109 % 10 = 9
So 83070-15-9 is a valid CAS Registry Number.

83070-15-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-(1,3-benzodioxol-5-yl)-2-chloroethanone

1.2 Other means of identification

Product number -
Other names chloromethyl 3,4-methylenedioxyphenyl ketone

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:83070-15-9 SDS

83070-15-9Relevant articles and documents

NEW ARYLALKENYLPROPARGYLAMINE DERIVATIVES EXHIBITING NEUROPROTECTIVE ACTION FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES

-

Page/Page column 23; 61, (2015/06/25)

The invention relates to novel arylalkenylpropargylamine derivatives of general formula (I) or enantiomers or diastereomers thereof or salts, optionally pharmaceutically acceptable salts, or solvates of any of these. The compounds can be used in treating or preventing a disease or condition in a mammal related to monoamine oxidase dysfunction, especially in neurodegenerative diseases, e.g. Parkinson's disease, Alzheimer's disease or Huntington's disease.

On Odoratin

Chatterjea, J. N.,Shaw, S. C.,Fatma, A.

, p. 990 - 992 (2007/10/02)

Two new syntheses of odoratin (1) are reported.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 83070-15-9